Radiology, Vol 206, 491-498, Copyright © 1998 by Radiological Society of North America

ARTICLES

Regression of HIV encephalopathy and basal ganglia signal intensity abnormality at MR imaging in patients with AIDS after the initiation of protease inhibitor therapy

CG Filippi, G Sze, SJ Farber, M Shahmanesh and PA Selwyn
Department of Radiology, Yale-New Haven Hospital, New Haven, CT 06504, USA.

PURPOSE: To determine whether protease inhibitors cause regression of periventricular white matter signal intensity abnormalities in patients with human immunodeficiency virus (HIV) encephalopathy and whether the changes on magnetic resonance (MR) images correlate with cognitive improvement. MATERIALS AND METHODS: MR images were retrospectively and prospectively analyzed in 16 adult patients with HIV encephalopathy. White matter and basal ganglia signal intensity abnormalities on initial long repetition time (TR) images were compared with those on subsequent long TR images in patients who received and in patients who did not receive protease inhibitors. Clinical correlation was obtained. RESULTS: Of the nine patients receiving protease inhibitors, four showed nearly complete regression, four showed interval stability, and one showed slight progression. Thus, eight patients (89%) demonstrated either stability or improvement in white matter disease, which correlated with cognitive improvement. Of the seven patients not receiving protease inhibitors, six (86%) showed marked progression with a decline in cognitive function and one had no interval change. The difference between the two groups was statistically significant. Of the two patients receiving protease inhibitors who initially had basal ganglia signal intensity abnormalities, one demonstrated resolution and one nearly complete resolution subsequently. CONCLUSION: Although the patient population is small, protease inhibitors may cause regression of periventricular white matter and basal ganglia signal intensity abnormalities in HIV encephalopathy and may have a role in treatment.

This article has been cited by other articles:

				M. J. Repetto and J. M. Petitto Psychopharmacology in HIV-Infected Patients Psychosom Med, June 1, 2008; 70(5): 585 - 592. [Abstract] [Full Text] [PDF]

				S. J. Ferrando and C. Nims HIV-Associated Mania Treated With Electroconvulsive Therapy and Highly-Active Antiretroviral Therapy. Psychosomatics, March 1, 2006; 47(2): 170 - 174. [Full Text] [PDF]

				S. L. Archibald, E. Masliah, C. Fennema-Notestine, T. D. Marcotte, R. J. Ellis, J. A. McCutchan, R. K. Heaton, I. Grant, M. Mallory, A. Miller, et al. Correlation of In Vivo Neuroimaging Abnormalities With Postmortem Human Immunodeficiency Virus Encephalitis and Dendritic Loss Arch Neurol, March 1, 2004; 61(3): 369 - 376. [Abstract] [Full Text] [PDF]

				S. J. Ferrando, J. G. Rabkin, W. van Gorp, S.-H. Lin, and M. McElhiney Longitudinal Improvement in Psychomotor Processing Speed Is Associated With Potent Combination Antiretroviral Therapy in HIV-1 Infection J Neuropsychiatry Clin Neurosci, May 1, 2003; 15(2): 208 - 214. [Abstract] [Full Text] [PDF]

				N A Sibtain and R J S Chinn Imaging of the central nervous system in HIV infection Imaging, February 1, 2002; 14(1): 48 - 59. [Abstract] [Full Text] [PDF]

				C. G. Filippi, A. M. Ulu, E. Ryan, S. J. Ferrando, and W. van Gorp Diffusion Tensor Imaging of Patients with HIV and Normal-appearing White Matter on MR Images of the Brain AJNR Am. J. Neuroradiol., February 1, 2001; 22(2): 277 - 283. [Abstract] [Full Text] [PDF]

				G. ZAULI, D. MILANI, P. MIRANDOLA, M. MAZZONI, P. SECCHIERO, S. MISCIA, and S. CAPITANI HIV-1 Tat protein down-regulates CREB transcription factor expression in PC12 neuronal cells through a phosphatidylinositol 3-kinase/AKT/cyclic nucleoside phosphodiesterase pathway FASEB J, February 1, 2001; 15(2): 483 - 491. [Abstract] [Full Text] [PDF]

				C. Martin, G. Solders, A. Sonnerborg, and P. Hansson Antiretroviral therapy may improve sensory function in HIV-infected patients: A pilot study Neurology, June 13, 2000; 54(11): 2120 - 2127. [Abstract] [Full Text] [PDF]

				M. M. Thurnher, E. G. Schindler, S. A. Thurnher, H. Pernerstorfer-Schön, C. Kleibl-Popov, and A. Rieger Highly Active Antiretroviral Therapy for Patients with AIDS Dementia Complex: Effect on MR Imaging Findings and Clinical Course AJNR Am. J. Neuroradiol., April 1, 2000; 21(4): 670 - 678. [Abstract] [Full Text]